• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Key Elements in Determining Voriconazole Protein Binding Characteristics: Comment on "Determination of Plasma Unbound Fraction of Voriconazole in Patients Treated With a Prophylactic or a Curative Treatment".

作者信息

Vanstraelen Kim, Pauwels Steven, Oyaert Matthijs, Maertens Johan, Spriet Isabel

机构信息

*Clinical Pharmacology and Pharmacotherapy, KU Leuven Department of Pharmaceutical and Pharmacological Sciences †Clinical Department of Laboratory Medicine, University Hospitals Leuven ‡Clinical Department of Haematology, Acute Leukaemia and Stem Cell Transplantation Unit, University Hospitals Leuven, Leuven, Belgium.

出版信息

Ther Drug Monit. 2015 Aug;37(4):551-3. doi: 10.1097/FTD.0000000000000163.

DOI:10.1097/FTD.0000000000000163
PMID:25525765
Abstract
摘要

相似文献

1
Key Elements in Determining Voriconazole Protein Binding Characteristics: Comment on "Determination of Plasma Unbound Fraction of Voriconazole in Patients Treated With a Prophylactic or a Curative Treatment".确定伏立康唑蛋白结合特性的关键要素：评“接受预防性或治疗性治疗患者伏立康唑血浆游离分数的测定”
Ther Drug Monit. 2015 Aug;37(4):551-3. doi: 10.1097/FTD.0000000000000163.
2
Determination of plasma unbound fraction of voriconazole in patients treated with a prophylactic or a curative treatment.接受预防性或治疗性治疗患者伏立康唑血浆游离分数的测定。
Ther Drug Monit. 2014 Dec;36(6):752-8. doi: 10.1097/FTD.0000000000000095.
3
Determination of total and free voriconazole in human plasma: Application to pharmacokinetic study and therapeutic monitoring.人血浆中伏立康唑总量和游离伏立康唑的测定：在药代动力学研究和治疗监测中的应用。
J Pharm Biomed Anal. 2020 Jan 30;178:112952. doi: 10.1016/j.jpba.2019.112952. Epub 2019 Oct 25.
4
Investigation of Saliva as an Alternative to Plasma Monitoring of Voriconazole.唾液作为伏立康唑血浆监测替代物的研究。
Clin Pharmacokinet. 2015 Nov;54(11):1151-60. doi: 10.1007/s40262-015-0269-z.
5
Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels.伏立康唑的治疗药物监测有助于降低目标谷浓度不达标的患者比例。
Med Mycol. 2016 May;54(4):353-60. doi: 10.1093/mmy/myv099. Epub 2016 Jan 6.
6
No alteration of voriconazole concentration by plasmapheresis in a critically ill patient.在一名危重病患者中，血浆置换未改变伏立康唑的浓度。
Eur J Clin Pharmacol. 2019 Feb;75(2):287-288. doi: 10.1007/s00228-018-2582-6. Epub 2018 Oct 22.
7
Significance of monitoring plasma concentration of voriconazole in a patient with liver failure: A case report.监测肝衰竭患者伏立康唑血药浓度的意义：一例报告
Medicine (Baltimore). 2017 Oct;96(42):e8039. doi: 10.1097/MD.0000000000008039.
8
Therapeutic drug monitoring of voriconazole: validation of a novel ARK™ immunoassay and comparison with ultra-high performance liquid chromatography.伏立康唑的治疗药物监测：新型ARK™免疫分析法的验证及与超高效液相色谱法的比较
Clin Chem Lab Med. 2015 Apr;53(5):e135-9. doi: 10.1515/cclm-2014-0774.
9
Therapeutic drug monitoring of voriconazole in Japanese patients: analysis based on clinical practice data.日本患者伏立康唑的治疗药物监测：基于临床实践数据的分析
J Chemother. 2016 Jun;28(3):198-202. doi: 10.1179/1973947815Y.0000000057. Epub 2016 May 27.
10
Voriconazole Autoinduction and Saturable Metabolism After Cessation of Rifampin in a Patient With Invasive Central Nervous System Aspergillus: Importance of Therapeutic Drug Monitoring.一名侵袭性中枢神经系统曲霉菌病患者停用利福平后伏立康唑的自身诱导和饱和代谢：治疗药物监测的重要性
J Pharm Pract. 2019 Oct;32(5):589-594. doi: 10.1177/0897190018760621. Epub 2018 Mar 1.

引用本文的文献

1
Microdialysis of Voriconazole and its N-Oxide Metabolite: Amalgamating Knowledge of Distribution and Metabolism Processes in Humans.伏立康唑及其 N-氧化物代谢物的微透析：整合人体分布和代谢过程的知识。
Pharm Res. 2022 Dec;39(12):3279-3291. doi: 10.1007/s11095-022-03407-7. Epub 2022 Oct 21.
2
In Vitro Activity of Isavuconazole and Comparators against Clinical Isolates of the Mucorales Order.艾沙康唑及对照药物对毛霉目临床分离株的体外活性
Antimicrob Agents Chemother. 2015 Dec;59(12):7735-42. doi: 10.1128/AAC.01919-15. Epub 2015 Oct 5.